TY  - JOUR
AU  - Moreno-Garcia, E.
AU  - Puerta-Alcalde, P.
AU  - Gariup, G.
AU  - Fernandez-Ruiz, M.
AU  - Lopez Cortes, L. E.
AU  - Cuervo, G.
AU  - Salavert, M.
AU  - Merino, P.
AU  - Machado, M.
AU  - Guinea, J.
AU  - Garcia-Rodriguez, J.
AU  - Garnacho-Montero, J.
AU  - Cardozo, C.
AU  - Peman, J.
AU  - Montejo, M.
AU  - Fortun, J.
AU  - Almirante, B.
AU  - Castro, C.
AU  - Rodriguez-Bano, J.
AU  - Aguado, J. M.
AU  - Martinez, J. A.
AU  - Carratala, J.
AU  - Soriano, A.
AU  - Garcia-Vidal, C.
AU  - Project GEMICOMED SEIMC
PY  - 2021
DO  - 10.1093/ofid/ofab250
SN  - 2328-8957
UR  - https://hdl.handle.net/10668/27322
T2  - Open forum infectious diseases
AB  - Background. There are no clear criteria for antifungal de-escalation after initial empirical treatments. We hypothesized that early de-escalation (ED) (within 5 days) to fluconazole is safe in fluconazole-susceptible candidemia with controlled source...
LA  - en
PB  - Oxford univ press inc
KW  - antifungal
KW  - candidemia
KW  - de-escalation
KW  - invasive candidiasis
KW  - outcome
KW  - Critically-ill patients
KW  - De-escalation
KW  - Down therapy
KW  - Antifungal
KW  - Susceptibility
KW  - Candidaemia
KW  - Management
KW  - Guideline
KW  - Mortality
TI  - Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
TY  - research article
VL  - 8
ER  -